Interferons in relapsing remitting multiple sclerosis-Reference-Cited by-同舟云学术

Interferons in relapsing remitting multiple sclerosis

Published:2003-05 Issue:9371 Volume:361 Page:1824-1825
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Filippini Graziella,Munari Luca,Ebers George C,D'Amico Roberto,Rice George PA

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Systematic reviews in health care: assessing the quality of controlled clinical trials;Jüni;BMJ,2001

2. Design and analysis of randomised clinical trials requiring prolonged observation of each patient, part II: analysis and examples;Peto;BrJCancer,1977

3. Survival probabilities (the Kaplan-Meier method);Bland;BMJ,1998

4. Biogen. Summary basis of approval: FDA official document for license of interferon beta-Ia (Avonex). http://www.fda.gov/cber/products/ifnbbio051796.htm (accessed May 11, 2003).

5. Inter-and intrarater scoring agreement using grades 1.0 to 3.5 ofthe Kurtzke Expanded Disability Status Scale (EDSS);Goodkin;Neurology,1992

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: Is there an odd one Out?;Journal of Central Nervous System Disease;2012-01

2. References;McAlpine's Multiple Sclerosis;2006

3. Proper interpretation and analysis of censored events and studies that contain them;Multiple Sclerosis Journal;2005-12

4. Indolin-2-ones with High in Vivo Efficacy in a Model for Multiple Sclerosis;Journal of Medicinal Chemistry;2005-07-27

5. Clinical Trials;Wiley Series in Probability and Statistics;2005-07-08